These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 21542505

  • 1. GAO looks at bundling outside ESRD.
    Neumann ME.
    Nephrol News Issues; 2011 Apr; 25(4):8. PubMed ID: 21542505
    [No Abstract] [Full Text] [Related]

  • 2. Erythropoietin & ESRD payments: a promising policy outcome?
    Roe W.
    Nephrol News Issues; 1989 Sep; 3(9):34-5. PubMed ID: 2682270
    [No Abstract] [Full Text] [Related]

  • 3. Medicare prescription plan, threat to AWP could impact the ESRD drug market.
    Neumann ME.
    Nephrol News Issues; 2003 Jan; 17(2):16-7, 21. PubMed ID: 12629823
    [No Abstract] [Full Text] [Related]

  • 4. Surviving change: Can the ESRD provisions in the SCHIP create a level playing field?
    Gardner AV.
    Nephrol News Issues; 2007 Sep; 21(10):52-3. PubMed ID: 17918480
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The direction of end-stage renal disease reimbursement in the United States.
    Lockridge RS.
    Semin Dial; 2004 Sep; 17(2):125-30. PubMed ID: 15043614
    [Abstract] [Full Text] [Related]

  • 7. Moving toward a patient-centered payment system for ESRD beneficiaries.
    Augustine BA.
    Nephrol News Issues; 2004 May; 18(6):35. PubMed ID: 15160418
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Health insurance exchanges and ESRD.
    Schrag WF.
    Nephrol News Issues; 2014 Jan; 28(1):18. PubMed ID: 24600925
    [No Abstract] [Full Text] [Related]

  • 10. Futuristic plans for ESRD--a new bundled payment system.
    Michael M.
    Nephrol News Issues; 2005 Sep; 19(10):52, 54. PubMed ID: 16187649
    [No Abstract] [Full Text] [Related]

  • 11. Medicare program; end-stage renal disease prospective payment system. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS.
    Fed Regist; 2010 Aug 12; 75(155):49029-214. PubMed ID: 20712086
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Carrier payment delays biggest problem for ESRD facilities.
    Paganini E.
    Nephrol News Issues; 1990 Apr 12; 4(4):39-42. PubMed ID: 2333120
    [No Abstract] [Full Text] [Related]

  • 16. Who should be paying for vitamin D analogues--Medicare or the patients?
    Hall G.
    Nephrol Nurs J; 2006 Apr 12; 33(3):345-6, 351. PubMed ID: 16859205
    [No Abstract] [Full Text] [Related]

  • 17. Reduction in ESRD reimbursement rate: identifying research priorities and quality indicators.
    Parker J.
    ANNA J; 1990 Apr 12; 17(2):147-54. PubMed ID: 2183724
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Can your patients afford a transplant?
    Forsthoffer F, Thomas C.
    Nephrol News Issues; 1999 Aug 12; 13(8):11-6. PubMed ID: 10765231
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.